دورية أكاديمية
Frequency of exacerbations in patients with chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort
| العنوان: | Frequency of exacerbations in patients with chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort |
|---|---|
| المؤلفون: | Han, MK, Quibrera, PM, Carretta, EE, Barr, RG, Bleecker, ER, Bowler, RP, Cooper, CB, Comellas, A, Couper, DJ, Curtis, JL, Criner, G, Dransfield, MT, Hansel, NN, Hoffman, EA, Kanner, RE, Krishnan, JA, Martinez, CH, Pirozzi, CB, O'Neal, WK, Rennard, S, Tashkin, DP, Wedzicha, JA, Woodruff, P, Paine, R, Martinez, FJ |
| المساهمون: | Medical Research Council (MRC) |
| المصدر: | 626 ; 619 |
| بيانات النشر: | Elsevier |
| سنة النشر: | 2017 |
| المجموعة: | Imperial College London: Spiral |
| مصطلحات موضوعية: | Science & Technology, Life Sciences & Biomedicine, Critical Care Medicine, Respiratory System, General & Internal Medicine, COMPUTED-TOMOGRAPHY, COPD, DECLINE, SPIROMICS investigators |
| الوصف: | Background Present treatment strategies to stratify exacerbation risk in patients with chronic obstructive pulmonary disease (COPD) rely on a history of two or more events in the previous year. We aimed to understand year to year variability in exacerbations and factors associated with consistent exacerbations over time. Methods In this longitudinal, prospective analysis of exacerbations in the Subpopulations and Intermediate Outcome Measures in COPD Study (SPIROMICS) cohort, we analysed patients aged 40–80 years with COPD for whom 3 years of prospective data were available, identified through various means including care at academic and non-academic medical centres, word of mouth, and existing patient registries. Participants were enrolled in the study between Nov 12, 2010, and July 31, 2015. We classified patients according to yearly exacerbation frequency: no exacerbations in any year; one exacerbation in every year during 3 years of follow-up; and those with inconsistent exacerbations (individuals who had both years with exacerbations and years without during the 3 years of follow-up). Participants were characterised by the Global Initiative for Chronic Obstructive Lung Disease (GOLD) spirometric category (1–4) on the basis of post-bronchodilator FEV1. Stepwise logistic regression was used to compare factors associated with one or more acute exacerbations of COPD every year for 3 years versus no exacerbations in the same timeframe. Additionally, a stepwise zero-inflated negative binomial model was used to assess predictors of exacerbation count during follow-up in all patients with available data. Baseline symptom burden was assessed with the COPD assessment test. This trial is registered with ClinicalTrials.gov, number NCT01969344. Findings 2981 patients were enrolled during the study. 1843 patients had COPD, of which 1105 patients had 3 years of complete, prospective follow-up data. 538 (49%) of 1105 patients had at least one acute exacerbation during the 3 years of follow-up, whereas 567 (51%) had none. ... |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| تدمد: | 2213-2600 |
| العلاقة: | Lancet Respiratory Medicine; http://hdl.handle.net/10044/1/49925Test; https://dx.doi.org/10.1016/S2213-2600Test(17)30207-2; G0800570/2 |
| DOI: | 10.1016/S2213-2600(17)30207-2 |
| الإتاحة: | https://doi.org/10.1016/S2213-2600Test(17)30207-2 http://hdl.handle.net/10044/1/49925Test |
| حقوق: | © 2017 Elsevier Ltd. All rights reserved. This manuscript is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International http://creativecommons.org/licenses/by-nc-nd/4.0Test/ |
| رقم الانضمام: | edsbas.DC9502BE |
| قاعدة البيانات: | BASE |
| تدمد: | 22132600 |
|---|---|
| DOI: | 10.1016/S2213-2600(17)30207-2 |